ETHNOPHARMACOLOGICAL RELEVANCE: Several medicinal plants and spices are used traditionally to treat cancers in Cameroon. AIM: Methanol extracts from thirty-four spices and plants, with related ethnobotanical use were investigated for their in vitro cytotoxicity on the human pancreatic cancer cell line MiaPaCa-2, leukemia CCRF-CEM cells and their multidrug resistant (MDR) subline CEM/ADR5000, and the normal human umbilical vein endothelial cells (HUVECs). In addition the anti-angiogenic properties of the most active extracts were investigated. MATERIAL AND METHODS: The MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay was used for cytotoxic studies and the CAM-assay (chicken-chorioallantoic-membrane-assay) for anti-angiogenesis test. RESULTS: The results of the cytotoxicity tests indicated that, when tested at 20 μg/ml, extracts from Xylopia aethiopica, Echinops giganteus, Imperata cylindrica, Dorstenia psilirus and Piper capense were able to inhibit more that 50% the proliferation of the three tested cancer cells (MiaPaCa-2, CEM/ADR5000 CCRF-CEM). The lowest IC(50) values of 6.86 μg/ml on MiaPaCa-2 and 3.91 μg/ml on CCRF-CEM cells were obtained with X. aethiopica, while the corresponding value of 6.56 μg/ml was obtained with P. capense on CEM/ADR5000 cells. Against leukemia cells, no cross-resistance was observed with I. cylindrica, P. capense and Zinziber officinalis. Extracts from D. psilirus and E. giganteus were able to inhibit angiogenesis by more than 50% in quail embryo. CONCLUSION: The overall results of the present study provide supportive data on the use of some Cameroonian plants for cancer treatment.
ETHNOPHARMACOLOGICAL RELEVANCE: Several medicinal plants and spices are used traditionally to treat cancers in Cameroon. AIM: Methanol extracts from thirty-four spices and plants, with related ethnobotanical use were investigated for their in vitro cytotoxicity on the humanpancreatic cancer cell line MiaPaCa-2, leukemia CCRF-CEM cells and their multidrug resistant (MDR) subline CEM/ADR5000, and the normal human umbilical vein endothelial cells (HUVECs). In addition the anti-angiogenic properties of the most active extracts were investigated. MATERIAL AND METHODS: The MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay was used for cytotoxic studies and the CAM-assay (chicken-chorioallantoic-membrane-assay) for anti-angiogenesis test. RESULTS: The results of the cytotoxicity tests indicated that, when tested at 20 μg/ml, extracts from Xylopia aethiopica, Echinops giganteus, Imperata cylindrica, Dorstenia psilirus and Piper capense were able to inhibit more that 50% the proliferation of the three tested cancer cells (MiaPaCa-2, CEM/ADR5000 CCRF-CEM). The lowest IC(50) values of 6.86 μg/ml on MiaPaCa-2 and 3.91 μg/ml on CCRF-CEM cells were obtained with X. aethiopica, while the corresponding value of 6.56 μg/ml was obtained with P. capense on CEM/ADR5000 cells. Against leukemia cells, no cross-resistance was observed with I. cylindrica, P. capense and Zinziber officinalis. Extracts from D. psilirus and E. giganteus were able to inhibit angiogenesis by more than 50% in quail embryo. CONCLUSION: The overall results of the present study provide supportive data on the use of some Cameroonian plants for cancer treatment.
Authors: Simplice B Tankeo; Stephen T Lacmata; Jaures A K Noumedem; Jean P Dzoyem; Jules R Kuiate; Victor Kuete Journal: Chin J Integr Med Date: 2014-06-28 Impact factor: 1.978
Authors: Brice E N Wamba; Paramita Ghosh; Armelle T Mbaveng; Sayantan Bhattacharya; Mitra Debarpan; Saha Depanwita; Mustafi Mitra Saunak; Victor Kuete; Nabendu Murmu Journal: Evid Based Complement Alternat Med Date: 2021-01-18 Impact factor: 2.629
Authors: Igor K Voukeng; Victor Kuete; Jean P Dzoyem; Aimé G Fankam; Jaures A K Noumedem; Jules R Kuiate; Jean-Marie Pages Journal: BMC Res Notes Date: 2012-06-15
Authors: Victor Kuete; Hippolyte K Wabo; Kenneth O Eyong; Michel T Feussi; Benjamin Wiench; Benjamin Krusche; Pierre Tane; Gabriel N Folefoc; Thomas Efferth Journal: PLoS One Date: 2011-08-19 Impact factor: 3.240
Authors: Aimé G Fankam; Victor Kuete; Igor K Voukeng; Jules R Kuiate; Jean-Marie Pages Journal: BMC Complement Altern Med Date: 2011-11-01 Impact factor: 3.659
Authors: Mahmoud Youns; Momen Askoura; Hisham A Abbas; Gouda H Attia; Ahdab N Khayyat; Reham M Goda; Ahmad J Almalki; El-Sayed Khafagy; Wael A H Hegazy Journal: Onco Targets Ther Date: 2021-06-23 Impact factor: 4.147